| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-12 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-11 |
| mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-11 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-11 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-10 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-10 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-10 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-09 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-08 |